We Accept amex

Formerly known as Maylips.com

info@directdoctorsupply.com+1-800-325-7104

Logo Logo
Track delivery Wishlist
  • 0 $ 0.00
  • Products
    • All Products
    • Peptides NEW
    • Anaesthetics
    • Body Sculpting
    • Botulinum Toxin
    • Cannulas and Needles
    • Cellular Rejuvenation
    • Dermal Filler Removal
    • Dermal Fillers
      • Biostimulators
      • HA Dermal Fillers
      • Korean Dermal Fillers
      • Polynucleotides
      • Skinboosters
    • Exosomes
    • Eyelash Enhancers
    • Fat Removal
    • Gynecology
    • Mesotherapy
    • IV Therapy
    • Orthopedic Injections
    • Peels and Masks
    • PRP Kits
    • Skincare
    • Threads
      • PCLA Threads
      • PDO Threads
      • PLA Threads
    • Weight Loss
  • Brands
    • ALIAXIN®
    • ALIDYA™
    • AQUALYX®
    • AZZALURE®
    • BCN
    • BELLAST®
    • BELOTERO®
    • BIOREPEELCL3®
    • BOCOUTURE® (XEOMIN®)
    • BOTOX®
    • CAREGEN
    • CINGAL®
    • CRESPINE®
    • CROMA
    • CYTOCARE
    • DEPO-PROVERA®
    • DERMALAX™
    • DESIRIAL®
    • DUROLANE®
    • DYSPORT®
    • EJAL
    • ELLANSÉ™
    • EMLA™
    • Euflexxa
    • FILLMED®
    • FILORGA®
    • GARDASIL®
    • HArmonyCA™
    • HYACORP
    • HYAFILIA®
    • HYALGAN®
    • HYMOVIS®
    • HYNIDASE®
    • INTRALINE®
    • JALUPRO®
    • JAYDESS®
    • JUVÉDERM®
    • KARISMA
    • LEMONBOTTLE
    • LANLUMA
    • LIPORASE®
    • MEDIDERMA®
    • MESO-RELLE®
    • MESOESTETIC®
    • MICRONJET™
    • MIRENA®
    • MONOVISC®
    • MOUNJARO®
    • NEAUVIA™
    • NEURAMIS®
    • NEXPLANON®
    • NITHYA
    • NOVERA COMPOUNDS
    • NUCLEOFILL™
    • ORTHOVISC®
    • OZEMPIC®
    • PERFECTHA®
    • PLASMOLIFTING™
    • PROFHILO®
    • ​PROSTROLANE®
    • PRX-T33®
    • RADIESSE®
    • RAINBOW
    • REFINE
    • REJURAN®
    • REJUVANAD+
    • REFINE
    • RESTYLANE®
    • REVANESSE®
    • REVOFIL
    • REVOLAX™
    • SAXENDA®
    • SAYPHA®
    • SCULPTRA®
    • SESDERMA®
    • SILHOUETTE
    • SMB®
    • SOFTFIL®
    • STYLAGE®
    • SUNEKOS®
    • SUPARTZ®
    • SYNVISC®
    • T-SAFE®
    • TEOSYAL®
    • ​THERASET®
    • VISCODERM®
    • WEGOVY®
    • XEOMIN®
    • ZO®
  • Peptides NEW
  • Sale
  • Shipping
  • Contact
  • About Us
  • Referral Program
  • Blog
  • Sign In / Register
Logo Logo
Menu
Close
Wishlist
  • Products
    • All Products
    • Peptides NEW
    • Anaesthetics
    • Body Sculpting
    • Botulinum Toxin
    • Cannulas and Needles
    • Cellular Rejuvenation
    • Dermal Filler Removal
    • Dermal Fillers
      • Biostimulators
      • HA Dermal Fillers
      • Korean Dermal Fillers
      • Polynucleotides
      • Skinboosters
    • Exosomes
    • Eyelash Enhancers
    • Fat Removal
    • Gynecology
    • Mesotherapy
    • IV Therapy
    • Orthopedic Injections
    • Peels and Masks
    • PRP Kits
    • Skincare
    • Threads
      • PCLA Threads
      • PDO Threads
      • PLA Threads
    • Weight Loss
  • Brands
    • ALIAXIN®
    • ALIDYA™
    • AQUALYX®
    • AZZALURE®
    • BCN
    • BELLAST®
    • BELOTERO®
    • BIOREPEELCL3®
    • BOCOUTURE® (XEOMIN®)
    • BOTOX®
    • BOTULAX®
    • CAREGEN
    • CINGAL®
    • CRESPINE®
    • CROMA
    • CYTOCARE
    • DEPO-PROVERA®
    • DERMALAX™
    • DESIRIAL®
    • DUROLANE®
    • DYSPORT®
    • EJAL
    • ELLANSÉ™
    • EMLA™
    • Euflexxa
    • FILLMED®
    • FILORGA®
    • GARDASIL®
    • HArmonyCA™
    • HYACORP
    • HYAFILIA®
    • HYALGAN®
    • HYMOVIS®
    • HYNIDASE®
    • INNOTOX®
    • INTRALINE®
    • JALUPRO®
    • JAYDESS®
    • JUVÉDERM®
    • KAIMAX
    • KARISMA
    • LEMONBOTTLE
    • LETYBO®
    • LANLUMA
    • LIPORASE®
    • LIZTOX®
    • MEDIDERMA®
    • MEDITOXIN®
    • MESO-RELLE®
    • MESOESTETIC®
    • MICRONJET™
    • MIRENA®
    • MONOVISC®
    • MOUNJARO®
    • NABOTA® (JEUVEAU®)
    • NEAUVIA™
    • NEURAMIS®
    • NEXPLANON®
    • NITHYA
    • NOVERA COMPOUNDS
    • NUCLEOFILL™
    • ORTHOVISC®
    • OZEMPIC®
    • PERFECTHA®
    • PLASMOLIFTING™
    • PROFHILO®
    • ​PROSTROLANE®
    • PRX-T33®
    • RADIESSE®
    • RAINBOW
    • Re N Tox™
    • REFINE
    • REJURAN®
    • REJUVANAD+
    • REFINE
    • RESTYLANE®
    • REVANESSE®
    • REVOFIL
    • REVOLAX™
    • SAXENDA®
    • SAYPHA®
    • SCULPTRA®
    • SESDERMA®
    • SILHOUETTE
    • SMB®
    • SOFTFIL®
    • STYLAGE®
    • SUNEKOS®
    • SUPARTZ®
    • SYNVISC®
    • T-SAFE®
    • TEOSYAL®
    • ​THERASET®
    • VISCODERM®
    • WEGOVY®
    • XEOMIN®
    • ZO®
  • Peptides NEW
  • Sale
  • Shipping
  • Contact
  • About Us
  • Referral Program
  • Blog
  • Sign In / Register
  • 0 $ 0.00
Direct Doctor SupplyProduct BrandsEUFLEXXA®
Product Category
  • Anaesthetics (2)
  • Body Sculpting (4)
  • Botulinum Toxins (33)
  • Cannulas and Needles (13)
  • Cellular Rejuvenation (1)
  • Dermal Filler Removal (2)
  • Dermal Fillers (192)
  • Biostimulators (10)
  • HA Dermal Fillers (129)
  • Korean Dermal Fillers (28)
  • Polynucleotides (17)
  • Skinboosters (16)
  • Exosomes (1)
  • Eyelash Enhancers (1)
  • Fat Removal (3)
  • Gynecology (8)
  • IV Therapy (2)
  • Mesotherapy (23)
  • Orthopedic Injections (11)
  • Peels and Masks (23)
  • Peptides for Research (45)
  • Aesthetic & Cosmetic Peptides (1)
  • Brain, Cognitive & Nootropic Peptides (4)
  • Healing & Regenerative Peptides (6)
  • Immune & Thymic Peptides (4)
  • Longevity & Anti-Aging Peptides (7)
  • Muscle Growth & Performance Peptides (11)
  • Sexual Health & Hormonal Peptides (3)
  • Weight Loss & Metabolic Peptides (11)
  • PRP Kits (1)
  • Skincare (26)
  • Threads (28)
  • PCLA Threads (3)
  • PDO Threads (20)
  • PLA Threads (3)
  • Weight Loss (24)
Product Brand
  • ALIAXIN® (6)
  • ALIDYA™ (1)
  • AQUALYX® (1)
  • AZZALURE® (1)
  • BCN (12)
  • BELLAST® (3)
  • BELOTERO® (7)
  • BIOMEDICO (3)
  • BIOREPEELCL3® (2)
  • BOCOUTURE® (XEOMIN®) (3)
  • BOTOX® (6)
  • CAREGEN (2)
  • CINGAL® (1)
  • CRESPINE® (1)
  • CROMA (4)
  • CYTOCARE (4)
  • DEPO-PROVERA® (1)
  • DERMALAX™ (3)
  • DESIRIAL® (2)
  • DUROLANE® (1)
  • DYSPORT® (4)
  • EJAL (1)
  • ELLANSÉ™ (2)
  • EMLA™ (2)
  • EUFLEXXA® (1)
  • EXOJUV (1)
  • FILLMED® (14)
  • FILORGA® (2)
  • GARDASIL® (1)
  • HArmonyCA™ (1)
  • HYACORP (5)
  • HYAFILIA® (2)
  • HYALGAN® (1)
  • HYMOVIS® (1)
  • HYNIDASE® (1)
  • INTRALINE® (24)
  • JALUPRO® (5)
  • JAYDESS® (1)
  • JUVÉDERM® (13)
  • KARISMA (1)
  • LANLUMA (1)
  • LEMONBOTTLE (1)
  • LIPORASE® (1)
  • MEDIDERMA® (26)
  • MESO-RELLE® (2)
  • MESOESTETIC® (2)
  • MICRONJET™ (1)
  • MIRENA® (1)
  • MONOVISC® (1)
  • MOUNJARO® (9)
  • NEAUVIA™ (11)
  • NEURAMIS® (1)
  • NEXPLANON® (2)
  • NITHYA (3)
  • NOVERA COMPOUNDS (46)
  • NUCLEOFILL™ (8)
  • ORTHOVISC® (1)
  • OZEMPIC® (8)
  • PERFECTHA® (4)
  • PLASMOLIFTING™ (1)
  • PLINEST® (5)
  • PROFHILO® (3)
  • ​PROSTROLANE® (1)
  • PRX-T33® (1)
  • RADIESSE® (3)
  • RAINBOW (7)
  • REFINE (3)
  • REJURAN® (3)
  • REJUVANAD+ (2)
  • RENEFIL (3)
  • RESTYLANE® (10)
  • REVANESSE® (6)
  • REVOFIL (9)
  • REVOLAX™ (4)
  • SAXENDA® (1)
  • SAYPHA® (6)
  • SCULPTRA® (1)
  • SESDERMA® (10)
  • SILHOUETTE (3)
  • SMB® (1)
  • SOFTFIL® (6)
  • STYLAGE® (25)
  • SUNEKOS® (4)
  • SUPARTZ® (1)
  • SYNVISC® (2)
  • T-SAFE® (1)
  • TEOSYAL® (12)
  • ​THERASET® (1)
  • ULTRA V® (1)
  • VISCODERM® (2)
  • WEGOVY® (6)
  • XEOMEEN® (1)
  • XEOMIN® (4)
  • ZO® (3)

Buy EUFLEXXA®

Showing the single result

Sort By:
  • FERRING EUFLEXXA 3X2ML 01FERRING EUFLEXXA 3X2ML 02
    EUFLEXXA® (Italian)
    $ 239.00
    Add To Cart
    -+

EUFLEXXA® is an FDA-approved non-avian sodium hyaluronate viscosupplement for knee pain due to osteoarthritis. Each prefilled syringe delivers 20 mg of biofermentation-derived hyaluronan in 2 mL, administered as a three-injection weekly course directly into the knee joint. Licensed practitioners looking to buy EUFLEXXA® for their clinic can browse the Maylips catalog below. As a trusted wholesale supplier of orthopedic medical devices since 2014, Maylips offers verified supply, competitive wholesale pricing, and dedicated support staff for practices across the United States and internationally.

About EUFLEXXA® — A Non-Avian Sodium Hyaluronate Option

EUFLEXXA® is an intra-articular hyaluronic acid medical device designed to supplement depleted hyaluronic acid in osteoarthritic knee joints, offering practitioners a non-avian sodium hyaluronate option. Its regulatory history originates with PMA application P010029, under which a predecessor product received FDA approval in 2004. A subsequent PMA supplement approved in 2011 established the EUFLEXXA® brand name, based on data from a large multicenter randomized clinical trial [3]. The product has maintained its regulatory standing since that original approval [3].

EUFLEXXA® is listed in FDA records with Ferring Pharmaceuticals, Inc. as the applicant and manufacturer [3]. A key characteristic distinguishing EUFLEXXA® from several competing viscosupplements is its manufacturing source: the sodium hyaluronate is produced via bacterial biofermentation, yielding a non-avian formulation free of animal-derived proteins [5]. Combined with its established clinical evidence base and long-standing reimbursement infrastructure, this has contributed to EUFLEXXA®’s position as a well-recognized option in viscosupplementation for knee osteoarthritis management.

Who Is EUFLEXXA® For? — Treatment Indications and Patient Profile

EUFLEXXA® is indicated for the relief of knee pain associated with osteoarthritis in patients whose symptoms have not responded adequately to conservative non-pharmacologic therapy and simple analgesics [5]. It is not indicated for joints other than the knee.

Two patient groups are particularly relevant to EUFLEXXA® treatment planning. The first is patients with a known or suspected sensitivity to avian proteins. Because EUFLEXXA® is produced through bacterial fermentation and contains no avian-derived material, it does not carry the avian allergy contraindications associated with rooster comb-derived viscosupplements [5]. This makes it a suitable option when avian-derived alternatives are contraindicated, or when a healthcare professional prefers to avoid screening for avian allergy as part of patient selection.

The second group is the broader population of knee osteoarthritis patients who have not achieved adequate pain relief through physical therapy, activity modification, and oral analgesics, and who are seeking a non-surgical management option before considering joint replacement. For these patients, the EUFLEXXA® knee injection offers a structured three-week intra-articular treatment course with clinical evidence of pain reduction through 26 weeks [1].

How EUFLEXXA® Works — Non-Avian HA Technology

In healthy knees, hyaluronic acid (HA) functions as both a lubricant and shock absorber within the synovial fluid, protecting cartilage surfaces during movement [2]. In osteoarthritis, the concentration and molecular weight of endogenous HA decline, producing synovial fluid that is less viscous and less effective at cushioning the joint [2]. EUFLEXXA® is designed to supplement this depleted hyaluronan environment through intra-articular delivery of purified sodium hyaluronate, restoring some of the molecular weight forms of hyaluronan that osteoarthritic joints lose over time.

The sodium hyaluronate in EUFLEXXA® has a molecular weight of 2.4 to 3.6 million daltons, placing it among the higher-molecular-weight, non-cross-linked HA products in the US market [5]. That puts it at the opposite end of the spectrum from the low molecular weight preparations, whose shorter forms of hyaluronan more closely resemble the degraded HA already present in an arthritic joint. A peer-reviewed rheological comparison published in Advances in Therapy found that EUFLEXXA® most closely resembled healthy human synovial fluid among the products evaluated, particularly in molecular structure and viscoelastic properties at physiologically relevant shear rates [2].

EUFLEXXA® is not a steroid, and it contains no corticosteroids or pharmacologically active anti-inflammatory agents [5]. Its mechanism is mechanical rather than pharmacological. It works by restoring the viscoelastic properties of synovial fluid, not by suppressing inflammation through drug activity. The EUFLEXXA® generic name is sodium hyaluronate, produced via bacterial biofermentation, a non-avian process that removes the concern of avian protein exposure [5]. The solution’s viscous consistency leads some clinic teams and patients to call it the EUFLEXXA® gel injection, though the labeled formulation is a non-cross-linked hyaluronan rather than a true cross-linked gel.

About the Manufacturer

The EUFLEXXA® manufacturer is Ferring Pharmaceuticals, Inc., listed in FDA records as the applicant and holder of the product’s premarket approval [3]. Ferring’s stewardship spans the product’s full history, from the original 2004 PMA approval through the 2011 supplement that established the current brand name and the clinical program supporting its labeled indication [3].

EUFLEXXA® Product Spotlight

EUFLEXXA® 20 mg/2 mL prefilled syringe is supplied packaged in a box of three syringes, representing one complete treatment course for a single knee [5]. Each sterile, single-use glass syringe contains 20 mg of sodium hyaluronate derived from bacterial biofermentation, formulated in 2 mL of phosphate-buffered saline at 1% (10 mg/mL), with sodium chloride and phosphate-buffering agents as additional components [5].

EUFLEXXA® dosage consists of one 2 mL intra-articular injection administered weekly for three consecutive weeks, with each syringe intended for a single treatment session in a single knee [5]. This three-injection course supports efficient treatment planning and inventory management in orthopedic and sports medicine settings.

Clinical support for this regimen comes from the FLEXX trial, a prospective, randomized, double-blind, multicenter study involving 588 patients across 37 US clinical sites [1]. The trial demonstrated statistically significant reductions in knee pain compared with saline placebo through 26 weeks of follow-up [1]. An open-label extension phase followed patients through a repeat three-injection course up to one year after the initial cycle, with a safety profile consistent with the original treatment phase and no significant new safety signals identified [1].

EUFLEXXA® injection cost is best quoted per account rather than from a single list price, since wholesale figures move with order volume and standing terms. Procurement teams planning a purchase can get current pricing from the Maylips support team before committing to a volume.

Why Practitioners Choose EUFLEXXA®

One reason practitioners choose EUFLEXXA® is its non-avian biofermentation origin. Because it contains no avian-derived proteins, it does not carry the contraindications associated with rooster comb-sourced products [5]. Practitioners can offer it to a broader patient population without the additional step of screening for avian sensitivities, which can simplify patient selection in high-volume orthopedic and sports medicine settings.

The second practical advantage is EUFLEXXA®’s established reimbursement pathway. It carries a dedicated HCPCS J-code and defined CPT reporting for the injection procedure, which keeps billing straightforward for clinic teams.

Clinicians occasionally search for EUFLEXXA® injection reviews before adopting a new viscosupplement. Peer-reviewed outcome data such as the FLEXX trial give a firmer basis for that decision than anecdotal user reports [1]. This matters most in multi-specialty practices, where the same clinicians who order viscosupplements also buy HA dermal fillers for aesthetic work and are already comfortable evaluating hyaluronic acid products on their documentation.

Administration and Injection Protocol

EUFLEXXA® is administered as an intra-articular injection into the knee joint under aseptic conditions [5]. Before each injection, any joint effusion or joint swelling present should be aspirated. Practitioners should refer to the product IFU for complete procedural guidance [5].

Several precautions apply. Skin preparation agents containing quaternary ammonium salts, including benzalkonium chloride, should be avoided, as they can cause sodium hyaluronate to precipitate [5]. Equipment previously exposed to benzalkonium chloride-containing solutions should not be used [5]. Patients are advised to avoid strenuous or prolonged weight-bearing activities for at least 48 hours following each injection. Refer to the IFU for the full patient guidance [5].

The FLEXX trial monitored outcomes for 26 weeks following the first injection, with pain reduction observed at multiple time points across that period [1]. Individual response depends on osteoarthritis severity, body weight, activity level, and other patient-specific factors.

Practitioners evaluating the success rate of EUFLEXXA® injections can refer to the FLEXX trial, in which three weekly injections produced a statistically significant reduction in pain compared with saline placebo from baseline to week 26, measured on a 100-mm VAS following a 50-foot walk test [1]. Secondary measures including WOMAC scores and OARSI responder rates also showed meaningful improvement in the EUFLEXXA® group [1]. Individual results depend on disease severity, patient characteristics, and other clinical variables.

Distribution and Market Availability

EUFLEXXA® is FDA-approved and has been commercially available in the US market since the original PMA approval in 2004 [3]. It is distributed through authorized medical device supply channels to licensed healthcare practitioners, orthopedic clinics, sports medicine practices, and hospital purchasing departments. Any healthcare professional evaluating supply should confirm that their distributor handles the product through documented channels with reliable shipping timelines.

Practitioners looking to order EUFLEXXA® for clinical use can buy EUFLEXXA® online through Maylips. Alongside viscosupplements, clinics can buy orthopedic injections and other joint treatments from the same catalog, which keeps procurement for a busy practice in one place. Practices that also run an aesthetic arm can buy dermal fillers through Maylips as well, so orthopedic and cosmetic ordering sit on a single platform.

Buy EUFLEXXA® Wholesale Through Maylips

Practices that buy EUFLEXXA® wholesale gain the most from a supplier that pairs verified product with responsive procurement support. Maylips has supplied licensed medical professionals since 2014 and structures its catalog for clinic and hospital purchasing teams. To buy EUFLEXXA® injection online in clinic quantities, or to discuss volume terms, teams can work directly with the Maylips support team, whose staff walk procurement through pricing and shipping before an order is placed.

Availability is limited to qualified professionals, and the support team can confirm current stock and account setup on request.

Regulatory Status and Billing

EUFLEXXA® holds FDA Premarket Approval under PMA P010029, with the 2011 PMA supplement (S008) establishing the current brand name and labeled indication [3]. EUFLEXXA® is regulated as a Class III medical device by the FDA’s Center for Devices and Radiological Health, not as a pharmaceutical drug, and its labeled indication is limited to intra-articular injection for knee osteoarthritis pain [3][5].

The EUFLEXXA® J code is the assigned HCPCS code J7323, described as “Hyaluronan or derivative, Euflexxa, for intra-articular injection, per dose” [4]. This is a per-dose code applicable to each injection in the treatment course. All billing and coding should be verified against current CMS guidance and confirmed with the applicable MAC prior to claim submission [4].

The EUFLEXXA® CPT code depends on technique: the injection is reported with CPT 20610 without ultrasound guidance, or CPT 20611 when ultrasound guidance with permanent recording and reporting is used [4]. Clinic teams looking up the CPT code for EUFLEXXA® should confirm modifier use, bilateral reporting, and unit reporting against current CMS and payer-specific requirements before submission [4].

EUFLEXXA® Copay Assistance

EUFLEXXA® copay assistance and other patient support programs may be available through Ferring Pharmaceuticals for eligible patients. Terms, eligibility criteria, and enrollment processes are subject to change. Practitioners and patients should contact Ferring directly to confirm current program availability and terms before advising on financial support options.

EUFLEXXA® vs Competing Viscosupplements

EUFLEXXA® vs ORTHOVISC®

Both EUFLEXXA® and ORTHOVISC® are non-avian viscosupplements produced via bacterial fermentation, with linear, non-cross-linked sodium hyaluronate structures. Practices comparing ORTHOVISC® vs EUFLEXXA® can buy ORTHOVISC® through Maylips and evaluate both options side by side. The primary distinction between them lies in molecular weight range, with EUFLEXXA® at the higher end of the non-cross-linked HA spectrum [2][5]. The rheological comparison published in Advances in Therapy found EUFLEXXA® more closely resembled healthy synovial fluid on several measured parameters [2].

EUFLEXXA® vs MONOVISC®

MONOVISC® is also non-avian and fermentation-derived, so the real difference is structural. It uses a cross-linked hyaluronan delivered as a single injection, whereas EUFLEXXA® keeps a linear-chain architecture closer to native hyaluronan and runs across three weekly visits [2]. Clinics that buy MONOVISC® tend to do so specifically for the one-visit convenience, which is worth weighing against the closer structural match EUFLEXXA® offers.

EUFLEXXA® vs HYALGAN®

HYALGAN® comes from rooster comb, so it carries the avian protein sensitivity contraindications that EUFLEXXA® avoids [5], and its standard schedule runs longer than the three-injection EUFLEXXA® course. For a patient panel where an avian-derived product is a better fit, the option to buy HYALGAN® sits alongside EUFLEXXA® in the same range, so you are not committing to one source across the whole practice.

EUFLEXXA® vs SYNVISC®

SYNVISC® (hylan G-F 20) is avian-derived and chemically cross-linked, giving it a gel-like consistency quite unlike EUFLEXXA®’s linear hyaluronan [2], and its rooster-comb origin brings the same avian-sensitivity contraindications EUFLEXXA® is free of [5]. Some clinicians still prefer the cross-linked gel for certain cases, and those who do can buy SYNVISC® when it suits the patient in front of them.

EUFLEXXA® vs SUPARTZ®

SUPARTZ® is an avian-derived sodium hyaluronate given over a longer schedule than EUFLEXXA®’s three weekly injections, and its avian origin again introduces contraindications that EUFLEXXA® does not carry [5]. Practices that buy SUPARTZ® usually keep it on hand for the patient groups where an avian product is appropriate and the extended course is clinically acceptable, rather than as a direct substitute for EUFLEXXA®.

EUFLEXXA® Safety Profile

The EUFLEXXA® safety database was established from 588 randomized patients in the FLEXX trial and extended through an open-label safety study over up to 52 weeks [1]. The most commonly reported adverse events include arthralgia, back pain, extremity pain, musculoskeletal pain, and joint swelling [1]. Additional events reported across both treatment and placebo arms include upper respiratory tract infection, nasopharyngitis, sinusitis, urinary tract infection, headache, diarrhea, nausea, and cough [1]. Transient pain and swelling at the injected joint are listed as expected post-injection reactions in the product labeling [5].

EUFLEXXA® side effects at the injection site are generally transient and self-resolving [1]. Most reported EUFLEXXA® side effects involve short-lived local reactions rather than systemic events. Patients with repeated exposure carry a theoretical risk of an immune response, though this has not been formally characterized in human studies [5]. The open-label extension phase of the FLEXX trial did not identify any significant new or escalating safety signals beyond those seen during the initial treatment phase, and EUFLEXXA® long term side effects beyond typical transient reactions are not documented in the available clinical data [1].

Contraindications include known hypersensitivity to hyaluronan preparations, active infection of the knee joint, and skin disease or infection at the injection site [5]. EUFLEXXA® must not be injected intravascularly and must not be administered through equipment previously used with benzalkonium chloride-containing solutions [5]. Safety and effectiveness have not been established in pregnant women, lactating women, or children [5].

FAQs

What is EUFLEXXA®?

EUFLEXXA® is an FDA-approved, non-avian sodium hyaluronate viscosupplement supplied as a 20 mg/2 mL prefilled syringe for intra-articular injection into the knee joint. The full treatment course consists of three consecutive weekly injections, indicated for knee pain due to osteoarthritis [1][3].

What is EUFLEXXA® used for?

EUFLEXXA® is used to relieve knee pain associated with osteoarthritis in patients whose symptoms have not responded adequately to conservative non-pharmacologic therapy and simple analgesics. It is indicated for the knee joint only [5].

How long does EUFLEXXA® take to work?

Response timing varies from patient to patient, so how long does it take for EUFLEXXA® to work depends on individual factors. The FLEXX trial assessed primary outcomes at 26 weeks following the first injection, with pain reduction observed at multiple time points throughout that period [1]. Response depends on disease severity and other clinical factors.

Is EUFLEXXA® a steroid?

No. EUFLEXXA® is a sodium hyaluronate medical device, not a corticosteroid. Its mechanism is mechanical, restoring the lubricating and cushioning properties of the knee’s synovial fluid rather than acting through anti-inflammatory drug activity. The EUFLEXXA® generic name is sodium hyaluronate, produced via bacterial fermentation, a non-avian process yielding a purified, animal-protein-free product [5].

What is the success rate of EUFLEXXA® injections?

In the FLEXX trial (n=588), three weekly EUFLEXXA® injections produced a statistically significant reduction in knee pain versus saline placebo through week 26 [1]. Individual results vary with disease severity and patient factors.

What are the long-term side effects of EUFLEXXA®?

No significant long-term effects beyond transient injection-site reactions emerged in the open-label safety study, which followed patients up to 52 weeks [1]. Serious adverse events are rare [5].

EUFLEXXA® vs SUPARTZ® — what’s the difference?

EUFLEXXA® is produced via bacterial biofermentation and contains no avian-derived material, whereas SUPARTZ® is sourced from rooster comb and carries contraindications for patients with avian sensitivity [5]. EUFLEXXA® also has a substantially higher molecular weight, placing it closer to the rheological profile of healthy synovial fluid [2]. SUPARTZ® is also typically administered over a longer injection course than EUFLEXXA®’s three-weekly injections.

Looking to buy EUFLEXXA® products?

Maylips has supplied licensed medical practitioners with orthopedic injectables and aesthetic devices since 2014. The Maylips catalog offers EUFLEXXA® for professional wholesale ordering, with transparent pricing, dedicated support staff, and reliable delivery structured for clinic procurement teams. To purchase EUFLEXXA® online or explore volume ordering options, browse the catalog above or reach out to the Maylips support team directly.

Citations and Resources about EUFLEXXA®

[1] Altman RD, Rosen JE, Bloch DA, Hatoum HT, Korner P. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Seminars in Arthritis and Rheumatism. 2009. https://pubmed.ncbi.nlm.nih.gov/19539353/

[2] Nicholls M, Manjoo A, Shaw P, Niazi F, Rosen J. A comparison between rheological properties of intra-articular hyaluronic acid preparations and reported human synovial fluid. Advances in Therapy. 2018. https://pubmed.ncbi.nlm.nih.gov/29542009/

[3] U.S. Food and Drug Administration. P010029 – Premarket Approval (PMA). FDA. 2026. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P010029

[4] Centers for Medicare & Medicaid Services. Billing and Coding: Hyaluronans Intra-articular Injections of (A52420). Last Updated 01/01/2026. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=52420&ver=63

[5] Ferring Pharmaceuticals. EUFLEXXA Prescribing Information / Patient Information. https://www.ferringusa.com/wp-content/uploads/sites/12/2024/04/EuflexxaPI-07-2016.pdf

All content on this website is intended for informational purposes and does not constitute medical advice.

Content prepared by Direct Doctor Supply’s editorial team.

Sourcing and accuracy for this page follow our Editorial Policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published.

SVG Logo Color cropped

info@directdoctorsupply.com

+1-800-325-7104

Book a MeetingTrack delivery
Trustpilot

Supported payment providers

Visa Mastercard American Express Google Pay Apple Pay

*Apple Pay and Google Pay are available via a personalized link provided by your account manager.

🔒 Transactions on this website meet strict PCI DSS compliance for your safety.

Product authenticity guaranteed: all products are sourced from licensed distributors and traceable by LOT number.

Company
  • About Us
  • FAQ
  • Contact Us
  • Referral Program
  • Sitemap
Follow Us
  • Facebook
  • Instagram
  • LinkedIn
Company
  • About Us
  • FAQ
  • Contact Us
  • Referral Program
Follow Us
  • Facebook
  • Instagram
  • Linkedin
Products
  • Anaesthetics
  • Body Sculpting
  • Botulinum Toxin
  • Needles and Cannula
  • Filler Removal
  • Dermal Fillers
  • Eyelash Enhancers
  • Fat Removal
  • Gynecology
  • Mesotherapy
  • Orthopaedic Injections
  • Peels and Masks
  • PRP Kits
  • Skincare
  • Threads
  • Weight Management
Products
  • Anaesthetics
  • Body Sculpting
  • Botulinum Toxin
  • Needles and Cannula
  • Filler Removal
  • Dermal Fillers
  • Eyelash Enhancers
  • Fat Removal
  • Gynecology
  • Mesotherapy
  • Orthopaedic Injections
  • Peels and Masks
  • PRP Kits
  • Skincare
  • Threads
  • Weight Management

All peptide products sold by Direct Doctor Supply are Research Use Only (RUO) and intended solely for laboratory and scientific research. They are not FDA-approved and not for human or veterinary use, clinical, diagnostic, or therapeutic purposes. By purchasing RUO materials, you confirm they will be handled by qualified personnel in a proper research setting and in compliance with regulations. Products must not be administered to humans or animals or represented as safe or effective for medical use. Use is at your own risk; Direct Doctor Supply assumes no liability for misuse or regulatory issues.

2026 Direct Doctor Supply All rights reserved.
Terms Of Use Privacy Policy Refund and Replacement Shipping & Delivery